FAST-IG Trademark

Trademark Overview

On Wednesday, September 11, 2019, a trademark application was filed for FAST-IG with the United States Patent and Trademark Office. The USPTO has given the FAST-IG trademark a serial number of 88612777. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, March 24, 2025. This trademark is owned by Chugai Seiyaku Kabushiki Kaisha (Chugai Pharmaceutical Co., Ltd.). The FAST-IG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use, namely, pharmaceutical antibodies or its fragments or its derivatives; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical use
fast-ig

General Information

Serial Number88612777
Word MarkFAST-IG
Filing DateWednesday, September 11, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, March 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 19, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use, namely, pharmaceutical antibodies or its fragments or its derivatives; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 20, 2019
Primary Code005
First Use Anywhere DateMonday, November 30, 2020
First Use In Commerce DateMonday, November 30, 2020

Trademark Owner History

Party NameChugai Seiyaku Kabushiki Kaisha (Chugai Pharmaceutical Co., Ltd.)
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 115-8543
JP
Party NameChugai Seiyaku Kabushiki Kaisha (Chugai Pharmaceutical Co., Ltd.)
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 115-0051
JP

Trademark Events

Event DateEvent Description
Wednesday, December 11, 2019ASSIGNED TO EXAMINER
Saturday, September 14, 2019NEW APPLICATION ENTERED
Friday, September 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 12, 2019NON-FINAL ACTION E-MAILED
Thursday, December 12, 2019NON-FINAL ACTION WRITTEN
Thursday, December 12, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 1, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 5, 2020ASSIGNED TO LIE
Wednesday, May 6, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 6, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 11, 2020SUSPENSION LETTER WRITTEN
Monday, May 11, 2020LETTER OF SUSPENSION E-MAILED
Monday, May 11, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, November 11, 2020SUSPENSION INQUIRY WRITTEN
Wednesday, November 11, 2020INQUIRY TO SUSPENSION E-MAILED
Wednesday, November 11, 2020NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, December 15, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, December 23, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 23, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 7, 2021NON-FINAL ACTION WRITTEN
Thursday, January 7, 2021NON-FINAL ACTION E-MAILED
Thursday, January 7, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 10, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 11, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 11, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 20, 2021FINAL REFUSAL WRITTEN
Thursday, May 20, 2021FINAL REFUSAL E-MAILED
Thursday, May 20, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, July 16, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, July 16, 2021EXPARTE APPEAL RECEIVED AT TTAB
Friday, July 16, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, July 16, 2021EX PARTE APPEAL-INSTITUTED
Tuesday, July 20, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 20, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 15, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 19, 2021PUBLISHED FOR OPPOSITION
Monday, September 27, 2021EXPARTE APPEAL TERMINATED
Tuesday, October 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 26, 2021TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, October 26, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, November 1, 2021WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Tuesday, November 2, 2021ASSIGNED TO PETITION STAFF
Wednesday, November 3, 2021WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Thursday, November 4, 2021REVIEW OF CORRESPONDENCE COMPLETE
Tuesday, December 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, January 7, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 7, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 11, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, May 11, 2022SOU EXTENSION 1 FILED
Wednesday, May 11, 2022SOU EXTENSION 1 GRANTED
Friday, May 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 21, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 23, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 23, 2022DIVISIONAL REQUEST RECEIVED
Wednesday, November 23, 2022SOU EXTENSION 2 FILED
Wednesday, November 23, 2022TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, December 7, 2022DIVISIONAL PROCESSING COMPLETE
Wednesday, December 7, 2022SOU EXTENSION 2 GRANTED
Thursday, December 8, 2022CORRECTED NOA E-MAILED
Thursday, December 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 10, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 10, 2023SOU EXTENSION 3 FILED
Wednesday, May 10, 2023SOU EXTENSION 3 GRANTED
Friday, May 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 16, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 16, 2023SOU EXTENSION 4 FILED
Monday, October 16, 2023SOU EXTENSION 4 GRANTED
Wednesday, October 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 15, 2024TEAS STATEMENT OF USE RECEIVED
Friday, May 24, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, June 3, 2024SU - NON-FINAL ACTION - WRITTEN
Monday, June 3, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 3, 2024NON-FINAL ACTION E-MAILED
Wednesday, June 12, 2024SOU TEAS EXTENSION RECEIVED
Monday, August 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 30, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 30, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 4, 2024FINAL REFUSAL E-MAILED
Wednesday, December 4, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, December 4, 2024SU - FINAL REFUSAL - WRITTEN
Monday, March 24, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, March 24, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Related Keywords

fast antibodies derivatives pharmaceutical fragments manufacture medical cells human preparations namely